Vitro Biopharma provides and continuously improves stem cells and related produducts and services according to applicable regulations. The discovery of embryonic stem cells capable of differentiation into any cell type of the body was largely responsible for the development of modern stem cell technology. Embryonic stem cells are also ethically contentious since, in certain cases, embryo destruction results from the use of embryonic stem cells. However, adult stem cells are derived through non-destructive procedures from a variety of tissue sources. Adult stem cells have been approved for clinical use for over 50 years and have a strong record of safety and efficacy for use in the treatment of numerous blood disorders and immunological conditions. Presently, the MSC sector of stem cell research is one of the most rapidly growing and expanding fields within the entire stem cell industry.
Vitro Biopharma News
Golden, Colorado-October 13, 2020 Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma announced the revocation of its SEC registration for Vitro Diagnostics, Inc while also announcing its plans for re-registration with the SEC. As noted in our prior releases,...
Golden, Colorado-Oct. 1, 2020-Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its 3rd quarter, ended July 31st 2020, financial results of operations. Vitro Biopharma recorded 3rd quarter revenues of $132,066 vs $225,191 a decrease of 41% over the...
Golden, Colorado-July20th, 2020-Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced that it has engaged MaloneBailey L.L.P. (Certified Public Accounting Firm www.malonebailey.com ) as its new auditors that will be auditing the company’s consolidated...
Our Products and Services
We are distinct from our competitors by a unique mix of proprietary formulations, technical know-how and patent-pending technology yielding substantial competitive advantages. Through our extensive commercial manufacturing experience, we are capable of highly efficient stem cell production yielding high margins for our clinical trial stem cell therapies. We also manufacture our own MSC-Gro media for all cellular manufacturing yielding further cost savings and additional manufacturing efficiencies.
With rigorous control of all cell culture parameters our clinical grade stem cells are not only economical but exhibit potency advantages as well that optimize superior clinical performance. In addition to Best in Class stem cell products for transplantation, we have also developed stem cell activation products targeting adult stem cells. This allows us to follow (or proceed) an adult stem cell transplant with further therapy to activate or differentiate stem cells to enhance and maximize the therapeutic benefit of a stem cell transplant. Our CLIA-registered laboratory also provides biomarker profiling of the stem cells for the quantitation of stem cell status and measurement of therapeutic effects.
Cell Culture Media
We have developed several novel cell culture media formulations through over 25 years of research in this field.
We provide human stem cell lines for use in research, drug discovery/development and pre-clinical studies.
Biomarker profiling plays an important role in drug discovery, diagnostics and molecular medicine.
Activate Stem Cells to Migrate and Produce New Stem Cells. Find out all the benefits it has to offer here!